Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Schizophrenia
Age: Adult
Dose: Oral – 5-10 mg
Frequency: once daily
Note: Initial dose; if necessary, may be titrated upward in increments of 5 mg/day at intervals greater than 1 week
Indication: Schizophrenia
Age: Adult
Dose: Oral – 10-20 mg
Frequency: once daily
Note: Maintenance dose; not to exceed 20 mg/day

Child Dose

Clinical InformationAdministration Information
Indication: Bipolar I Disorder (Manic or Mixed Episodes)
Age: less than 13 years
Dose: Oral – Safety and efficacy not established
Indication: Bipolar I Disorder (Manic or Mixed Episodes)
Age: 13-17 years
Dose: Oral – 2.5-5 mg/day initially; target dosage, 10 mg/day
Frequency: once daily
Note: by mouth (oral); adjust by increments/decrements of 2.5-5 mg; dosage range, 2.5-20 mg/day

Renal Dose

Clinical InformationAdministration Information
Condition: Renal impairment
Dose: Tablet – 5 mg
Frequency: once daily
Note: Initial dose
Administration
  • May be taken with or without food
  • Take at same time each day
Side Effect

Drug Interaction

Drug NameRisk Factors
Activated charcoal
Reduced oral bioavailability of olanzapine by 50-60%
Levodopa, Dopamine Agonists (Bromocriptine, Pergolide, Ropinirole, Pramipexole)
May antagonize effects

Disease Interaction

Disease NameRisk Factors
Angle-Closure Glaucoma
Can increase eye pressure
History of CVS Disease (IM)
Risk of cardiovascular complications

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage

Details coming soon

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.